Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics.

Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics.

Matrix metalloproteinases (MMPs) play a central role in many biological processes such as development, morphogenesis and wound healing, but their unbalanced activities are implicated in numerous disease processes such as arthritis, cancer metastasis, atherosclerosis, nephritis and fibrosis. One of t...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Nagase, H, Brew, K
Materialtyp:	Journal article
Språk:	English
Publicerad:	2002

Liknande verk

Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
av: Nagase, H, et al.
Publicerad: (2003)

Tissue inhibitors of metalloproteinases: evolution, structure and function.
av: Brew, K, et al.
Publicerad: (2000)

Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
av: Wei, S, et al.
Publicerad: (2003)

The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.
av: Brew, K, et al.
Publicerad: (2010)

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
av: Visse, R, et al.
Publicerad: (2003)

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) - Physiological roles and structural basis of MMP inhibition by TIMP-1
av: Nagase, H, et al.
Publicerad: (2000)

Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
av: Wei, S, et al.
Publicerad: (2005)

Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase.
av: Itoh, Y, et al.
Publicerad: (1995)

Engineered tissue inhibitor of metalloproteinases-3 variants resistant to endocytosis have prolonged chondroprotective activity
av: Doherty, C, et al.
Publicerad: (2016)

Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
av: Itoh, Y, et al.
Publicerad: (1995)

Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
av: Ogata, Y, et al.
Publicerad: (1995)

Structural features of the reprolysin atrolysin C and tissue inhibitors of metalloproteinases (TIMPs) interaction.
av: Pinto, A, et al.
Publicerad: (2006)

Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma.
av: Ogata, Y, et al.
Publicerad: (2001)

Matrix metalloproteinases and their inhibitors in human vitreous.
av: De La Paz, MA, et al.
Publicerad: (1998)

Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).
av: Kveiborg, M, et al.
Publicerad: (2010)

Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
av: Itoh, Y, et al.
Publicerad: (1998)

Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.
av: Kopitz, C, et al.
Publicerad: (2007)

The expression of tissue inhibitor of metalloproteinase 2 (TIMP-2) is required for normal development of zebrafish embryos.
av: Zhang, J, et al.
Publicerad: (2003)

Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors
av: Ahonen, M, et al.
Publicerad: (2002)

Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors.
av: Ahonen, M, et al.
Publicerad: (2003)

Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis.
av: Murphy, F, et al.
Publicerad: (2002)

Zymography of metalloproteinases.
av: Troeberg, L, et al.
Publicerad: (2004)

Connective tissue remodeling: cross-talk between endothelins and matrix metalloproteinases.
av: Abraham, D, et al.
Publicerad: (2005)

Matrix Metalloproteinase -9 and Tissue Inhibitors of Metalloproteinasr-1 and -2 as Potential Novel Biomakers in Gestational Hypertension
av: Ab Hamid, Jabrullah
Publicerad: (2010)

Suramin inhibits osteoarthritic cartilage degradation by increasing extracellular levels of chondroprotective tissue inhibitor of metalloproteinases 3 (TIMP-3)
av: Chanalaris, A, et al.
Publicerad: (2017)

N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.
av: Nuti, E, et al.
Publicerad: (2009)

Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassay.
av: Holten-Andersen, M, et al.
Publicerad: (2002)

Rhein, an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes.
av: Tamura, T, et al.
Publicerad: (2001)

Matrix metalloproteinases in cancer.
av: Itoh, Y, et al.
Publicerad: (2002)

Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.
av: Tousoulis, D, et al.
Publicerad: (2010)

Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis.
av: Jain, A, et al.
Publicerad: (2001)

Metalloproteinases in Rheumatoid Arthritis: Potential Therapeutic Targets to Improve Current Therapies
av: Itoh, Y
Publicerad: (2017)

Matrix metalloproteinases in chemoresistance: regulatory roles, molecular interactions, and potential inhibitors
av: Xin, Bernadette Jie Tune, et al.
Publicerad: (2022)

Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells.
av: Bafetti, L, et al.
Publicerad: (1998)

A personal journey with matrix metalloproteinases
av: Nagase, H
Publicerad: (2016)

Progress in matrix metalloproteinase research.
av: Murphy, G, et al.
Publicerad: (2008)

Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
av: Zhao, H, et al.
Publicerad: (2004)

Differential regulation of extracellular tissue inhibitor of metalloproteinases-3 levels by cell membrane-bound and shed low density lipoprotein receptor-related protein 1.
av: Scilabra, S, et al.
Publicerad: (2013)

Association of matrix metalloproteinase-1, 9, 12 and tissue inhibitor of metalloproteinase-1 gene polymorphisms in malay male essential hypertensive subject
av: Tabatabaee, Farizeh Aalam Ghomi
Publicerad: (2015)

MicroRNAs and their potential therapeutic applications in neural tissue engineering
av: Nguyen, Lan Huong, et al.
Publicerad: (2015)